Benjamin D. Hobson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Benjamin D. Hobson has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Peter Sims
Department of Systems Biology, Columbia University, New York, NY, USA
6 shared publications - David Sulzer
Columbia University
4 shared publications - Ryan K. Bachtell
University of Colorado Boulder
4 shared publications - Etienne Herzog
Univ. Bordeaux, CNRS, Interdisciplinary Institute for Neuroscience, IINS, Bordeaux, France
2 shared publications Eugene V. Mosharov
Department of Psychiatry, Columbia University Irving Medical Center, New York, NY 10032, USA
2 shared publications- Kari Christine Nadeau
Stanford University School of Medicine, Palo Alto, USA
2 shared publications
Latest Publications
- Open Access
- 30 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (5) , eady6978
α-Synuclein expression is required for somatodendritic dopamine release and immediate early gene induction
α-Synuclein (αSyn) is a presynaptic protein of unestablished physiological function that plays a central role in Parkinson’s disease neuropathology. To date, the reported effects of αSyn expression on the kinetics of axonal synaptic vesicle exocytosis and membrane cycling have been relatively small. In contrast, we report that αSyn is the major modulator of substantia nigra somatodendritic dopamine release, a little-understood form of neurotransmission that is central to sensorimotor and basal ganglia circuitry. This regulation is due to a previously unknown role for αSyn in controlling the activity of the L-type calcium ion channels (LTCC), which are also implicated in Parkinson’s pathogenesis. αSyn-deficient neurons further display decreased spike frequency adaptation, hippocampal LTCC-dependent long-term potentiation, and immediate early gene induction, functions that are essential for synaptic adaptation and neuronal plasticity.
- 30 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (5) , eady6978
Open Accessα-Synuclein expression is required for somatodendritic dopamine release and immediate early gene induction
α-Synuclein (αSyn) is a presynaptic protein of unestablished physiological function that plays a central role in Parkinson’s disease neuropathology. To date, the reported effects of αSyn expression on the kinetics of axonal synaptic vesicle exocytosis and membrane cycling have been relatively small. In contrast, we report that αSyn is the major modulator of substantia nigra somatodendritic dopamine release, a little-understood form of neurotransmission that is central to sensorimotor and basal ganglia circuitry. This regulation is due to a previously unknown role for αSyn in controlling the activity of the L-type calcium ion channels (LTCC), which are also implicated in Parkinson’s pathogenesis. αSyn-deficient neurons further display decreased spike frequency adaptation, hippocampal LTCC-dependent long-term potentiation, and immediate early gene induction, functions that are essential for synaptic adaptation and neuronal plasticity.
- 27 July 2023
- Published by Springer Nature in Nature Biotechnology
- Vol. 41 (9) , 1221-1224
Methodological concerns and lack of evidence for single-synapse RNA-seq
- 27 July 2023
- Published by Springer Nature in Nature Biotechnology
- Vol. 41 (9) , 1221-1224
Methodological concerns and lack of evidence for single-synapse RNA-seq
- Open Access
- 31 January 2022
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 11
Subcellular proteomics of dopamine neurons in the mouse brain
Dopaminergic neurons modulate neural circuits and behaviors via dopamine (DA) release from expansive, long range axonal projections. The elaborate cytoarchitecture of these neurons is embedded within complex brain tissue, making it difficult to access the neuronal proteome using conventional methods. Here, we demonstrate APEX2 proximity labeling within genetically targeted neurons in the mouse brain, enabling subcellular proteomics with cell-type specificity. By combining APEX2 biotinylation with mass spectrometry, we mapped the somatodendritic and axonal proteomes of midbrain dopaminergic neurons. Our dataset reveals the proteomic architecture underlying proteostasis, axonal metabolism, and neurotransmission in these neurons. We find that most proteins encoded by DA neuron-enriched genes are localized within striatal dopaminergic axons, including ion channels with previously undescribed axonal localization. These proteomic datasets provide a resource for neuronal cell biology, and this approach can be readily adapted for study of other neural cell types.
- 31 January 2022
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 11
Open AccessSubcellular proteomics of dopamine neurons in the mouse brain
Dopaminergic neurons modulate neural circuits and behaviors via dopamine (DA) release from expansive, long range axonal projections. The elaborate cytoarchitecture of these neurons is embedded within complex brain tissue, making it difficult to access the neuronal proteome using conventional methods. Here, we demonstrate APEX2 proximity labeling within genetically targeted neurons in the mouse brain, enabling subcellular proteomics with cell-type specificity. By combining APEX2 biotinylation with mass spectrometry, we mapped the somatodendritic and axonal proteomes of midbrain dopaminergic neurons. Our dataset reveals the proteomic architecture underlying proteostasis, axonal metabolism, and neurotransmission in these neurons. We find that most proteins encoded by DA neuron-enriched genes are localized within striatal dopaminergic axons, including ion channels with previously undescribed axonal localization. These proteomic datasets provide a resource for neuronal cell biology, and this approach can be readily adapted for study of other neural cell types.
- Open Access
- 11 January 2022
- Published by Elsevier in Cell Reports
- Vol. 38 (2) , 110208
Subcellular and regional localization of mRNA translation in midbrain dopamine neurons
- 11 January 2022
- Published by Elsevier in Cell Reports
- Vol. 38 (2) , 110208
Open AccessSubcellular and regional localization of mRNA translation in midbrain dopamine neurons
- Open Access
- 14 October 2021
- Published by Springer Nature
RiboTag Immunoprecipitation v1
This protocol describes an optimized method for RiboTag Immunoprecipitation from mouse brain tissue.
- 14 October 2021
- Published by Springer Nature
Open AccessRiboTag Immunoprecipitation v1
This protocol describes an optimized method for RiboTag Immunoprecipitation from mouse brain tissue.
- Open Access
- 26 August 2020
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 9
Elongation inhibitors do not prevent the release of puromycylated nascent polypeptide chains from ribosomes
Puromycin is an amino-acyl transfer RNA analog widely employed in studies of protein synthesis. Since puromycin is covalently incorporated into nascent polypeptide chains, anti-puromycin immunofluorescence enables visualization of nascent protein synthesis. A common assumption in studies of local messenger RNA translation is that the anti-puromycin staining of puromycylated nascent polypeptides in fixed cells accurately reports on their original site of translation, particularly when ribosomes are stalled with elongation inhibitors prior to puromycin treatment. However, when we attempted to implement a proximity ligation assay to detect ribosome-puromycin complexes, we found no evidence to support this assumption. We further demonstrated, using biochemical assays and live cell imaging of nascent polypeptides in mammalian cells, that puromycylated nascent polypeptides rapidly dissociate from ribosomes even in the presence of elongation inhibitors. Our results suggest that attempts to define precise subcellular translation sites using anti-puromycin immunostaining may be confounded by release of puromycylated nascent polypeptide chains prior to fixation.
- 26 August 2020
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 9
Open AccessElongation inhibitors do not prevent the release of puromycylated nascent polypeptide chains from ribosomes
Puromycin is an amino-acyl transfer RNA analog widely employed in studies of protein synthesis. Since puromycin is covalently incorporated into nascent polypeptide chains, anti-puromycin immunofluorescence enables visualization of nascent protein synthesis. A common assumption in studies of local messenger RNA translation is that the anti-puromycin staining of puromycylated nascent polypeptides in fixed cells accurately reports on their original site of translation, particularly when ribosomes are stalled with elongation inhibitors prior to puromycin treatment. However, when we attempted to implement a proximity ligation assay to detect ribosome-puromycin complexes, we found no evidence to support this assumption. We further demonstrated, using biochemical assays and live cell imaging of nascent polypeptides in mammalian cells, that puromycylated nascent polypeptides rapidly dissociate from ribosomes even in the presence of elongation inhibitors. Our results suggest that attempts to define precise subcellular translation sites using anti-puromycin immunostaining may be confounded by release of puromycylated nascent polypeptide chains prior to fixation.
- Open Access
- 22 May 2019
- Published by Society for Neuroscience in eneuro
- Vol. 6 (3)
Critical Analysis of Particle Detection Artifacts in Synaptosome Flow Cytometry
Flow cytometry and fluorescence-activated sorting are powerful techniques that hold great promise for studying heterogeneous populations of submicron particles such as synaptosomes, but many technical challenges arise in these experiments. To date, most flow cytometry studies of synaptosomes have relied on particle detection using forward scatter (FSC) measurements and size estimation with polystyrene (PS) bead standards. However, these practices have serious limitations, and special care must be taken to overcome the poor sensitivity of conventional flow cytometers in the analysis of submicron particles. Technical artifacts can confound these experiments, especially the detection of multiple particles as a single event. Here, we compared analysis of P2 crude synaptosomal preparations from murine forebrain on multiple flow cytometers using both FSC-triggered and fluorescence-triggered detection. We implemented multicolor fluorescent dye-based assays to quantify coincident particle detection and aggregation, and we assessed the false colocalization of antigens in immunostaining analyses. Our results demonstrate that fluorescence triggering and proper dilution can control for coincident particle detection, but not particle aggregation. We confirmed previous studies showing that FSC-based size estimation with PS beads underestimates biological particle size, and we identified pervasive aggregation in the FSC range analyzed in most synaptosome flow cytometry studies. We found that analyzing P2 samples in sucrose/EDTA/tris (SET) buffer reduces aggregation compared to PBS, but does not completely eliminate the presence of aggregates, especially in immunostaining experiments. Our study highlights challenges and pitfalls in synaptosome flow cytometry and provides a methodological framework for future studies.
- 22 May 2019
- Published by Society for Neuroscience in eneuro
- Vol. 6 (3)
Open AccessCritical Analysis of Particle Detection Artifacts in Synaptosome Flow Cytometry
Flow cytometry and fluorescence-activated sorting are powerful techniques that hold great promise for studying heterogeneous populations of submicron particles such as synaptosomes, but many technical challenges arise in these experiments. To date, most flow cytometry studies of synaptosomes have relied on particle detection using forward scatter (FSC) measurements and size estimation with polystyrene (PS) bead standards. However, these practices have serious limitations, and special care must be taken to overcome the poor sensitivity of conventional flow cytometers in the analysis of submicron particles. Technical artifacts can confound these experiments, especially the detection of multiple particles as a single event. Here, we compared analysis of P2 crude synaptosomal preparations from murine forebrain on multiple flow cytometers using both FSC-triggered and fluorescence-triggered detection. We implemented multicolor fluorescent dye-based assays to quantify coincident particle detection and aggregation, and we assessed the false colocalization of antigens in immunostaining analyses. Our results demonstrate that fluorescence triggering and proper dilution can control for coincident particle detection, but not particle aggregation. We confirmed previous studies showing that FSC-based size estimation with PS beads underestimates biological particle size, and we identified pervasive aggregation in the FSC range analyzed in most synaptosome flow cytometry studies. We found that analyzing P2 samples in sucrose/EDTA/tris (SET) buffer reduces aggregation compared to PBS, but does not completely eliminate the presence of aggregates, especially in immunostaining experiments. Our study highlights challenges and pitfalls in synaptosome flow cytometry and provides a methodological framework for future studies.
- Open Access
- 1 March 2019
- Published by Elsevier in Cell Reports
- Vol. 26 (12) , 3313-3322.e5
Widespread Alterations in Translation Elongation in the Brain of Juvenile Fmr1 Knockout Mice
- 1 March 2019
- Published by Elsevier in Cell Reports
- Vol. 26 (12) , 3313-3322.e5
Open AccessWidespread Alterations in Translation Elongation in the Brain of Juvenile Fmr1 Knockout Mice
- 3 November 2018
- Published by Springer Nature in Psychopharmacology
- Vol. 236 (2) , 699-708
Effects of adenosine A2A receptor antagonists on cocaine-induced locomotion and cocaine seeking
Adenosine signaling through adenosine A2A receptors (A2ARs) is known to influence cocaine-induced behaviors. These studies sought to elucidate how two A2AR antagonists distinguished by their antagonist effects at presynaptic and postsynaptic A2AR influence cocaine-induced locomotion and cocaine seeking.
- 3 November 2018
- Published by Springer Nature in Psychopharmacology
- Vol. 236 (2) , 699-708
Effects of adenosine A2A receptor antagonists on cocaine-induced locomotion and cocaine seeking
Adenosine signaling through adenosine A2A receptors (A2ARs) is known to influence cocaine-induced behaviors. These studies sought to elucidate how two A2AR antagonists distinguished by their antagonist effects at presynaptic and postsynaptic A2AR influence cocaine-induced locomotion and cocaine seeking.